Member Info for CHELSEA7

Taking 30k now at 7.52

Buys 34k

Sells 123k

For 30k

Well said violindog. Looks like ADMIN have deleted his post, IMHO they serve no purpose other than to create disharmomy. As I said yesterdaythe sentiment on the BB has been poor as a result, and I really hope we can now all go forward without these manmade arguments, which are pointless.

Just 20k sold in 2 trades and we can"t sell!!! Back to volatility.

7.50/8

Morning violindog, particularly happy you liked it. I didn"t get to see it till late afternoon, but the more i read it the more I liked it. Been 373k sells in two trades since yesterdays close so expecting those shares to be taken up during the day. 30 Trades yesterday, well up on recent weeks where we saw voumes over 1m a day on our rise to 10p. Same again today please.

A very interesting article, and i do wonder whether Rubal made it?

https://www.fiercebiotech.com/research/nano-immunotherapy-halts-glioblastoma-mice?mkt_tok=eyJpIjoiT1RFellXVTJOMlUxTmpKayIsInQiOiIyN3VjUEJtKzFkOHZQK2U2aHVQc0dxeXlJc0hKcXJ6TkpDNnlTblgwYWxYNk02Z1ZGeGxCSWJiYnRJUktPU213U2VBVUZiZGc2S0FcL3JndGx4SU5HNzA2ZVVJK0Y4cTRyYXQrVXRkdmFZdjJqeFB5M1ViUE9qbHBqVmR4cURnamgifQ%3D%3D&mrkid=36433381

103,672 Sell at 7.72, explaining the movement from 7.72 to 7.52. SCAP have moved to the ask now, going 2 v 2, not 3 v 1

Have we noticed to get sells our seller is now getting a premium over PIs,?? Anyway hence why SCAP moved back on the ask at 8.3p. A buyer will be flexing their muscles soon, and after the 103k sell, the amount of shares being taken has risen to 120k, whilst the price lowered to 7.52.

100k at 7.52, no corresponding trade explaining that.

SCAP have rejoined the SCRAP joining the bid again at 7.5. 3 MMs on bid and one on ask at 8.3

The last sell before the close was 7k at 7.50, despite the bid being 7.555 at the time, this morning the bid has risen to 7.72 for 100k, despite another 270k late last night at 7.65.

Can"t remember a time for a long time when the bid has risen by so much after every sell.

Will take 100k at 7.72, price up, quantity down, should rise all day.

Last night, again at 7.65 from 18.18, so the volume yesterday was 1.460m

Buys 715k

Sells 745k

Our buyer and seller accounted for 909k of trades yesterday, up from the previous range of 6.90/7.10.

I think we shall see more of the same today, and that RNS is IMHO getting even better on my sixth read of it this morning.

Lets have a great day.

Sells

So from having only a fictitious buyer, we have moved on to how do I know it is just the one buyer??

Progress eh? Regardless we rose over 12% yesterday announcing our third Platform, far from the rises we saw when we announced our second platforms all those years back but a nice rise on the build up to the AGM 2019. The irony of those who cannot answer a question to any of their posts, demanding others to do just that is remarkable. I would like to believe any posts on the subject have been well covered in recent weeks and months.

I do believe yesterdays rise is just the beginning of another bull run, just how much we will see later and through to next week.

After my mobile phone finally crashed on me on Tuesday, my computer folowed suit moments later, at least I got that back late yesterday, new hard drive intact, and running like lightning now,

Dracula, who dismissed you?? Can you just say who you are talking about.

I would imagine sentiment is low on this BB , not in the market, we have risen from the low where 16m shares got sold for 3p!!! Today 8.39 was paid and soon IMHO we will be back to double figures at the third attempt. Is sentiment low for those who bought in in the lows or for those LTH who managed to average down quite dramatically?? I didn"t buy more my 215k is enough for me and my average 15p is reachable, far more so than in many other shares in this sector.

We are reaching a point where there are many inflection points coming our way, a THIRD Platform announced today, with the company growing in resources and i feel any future fundings have been well thought out by Vulpes regardless of any commercial deals that may come our way.

Sentiment is low as the share price getting here has weakened year on year, like any companies in our position and the upside is enormous. Sentiment is also low because of the direct input of a few posters who make this BB tedious to read. Inhave no issues with you Dracula, I respond to your posts, you don"t respond back, I have no issues with the Knowlesi I knew who corresponded with me a few years back, I just have issues with his posts, his rudeness, he never answers a question and twists every post. I have no desire to have any issues with him either, I have my opinions with his posts, he creates a problem with mine.

So as ever if a few people decide to stage manage a war to suit, sentiment can go out of the window. Not a problem either I think Inanacos and Rays even crumbs post on topic are excellent, without those would know anything about the third Platform. I know one thing as a fact that group of posters will never input anything good and will continue to play the man not the ball.

So no issues for me, happy to hold, will be even happier to get to 15p which seems to be a figure that comes up quite a lot. It ia a shame we do not hear more from newer PIs or many LTHs, but with the staged dramatics that take place here i blame them not. Same old isn"t it accuse the good posters of shananagins, bring doubt on their intentions and then play victim, we have seen that for many years now.

So have a good evening, perhaps if some spent more time concentrating on the possibilities than they do disrespecting the board the BB would be better, but how doyou debate when a poster like we have refuses to answer any questions?? Tricky isn"t it. I sincerely hope we all do well here in time, the hatred is a sideshow nothing more, nothing less. Whi;st I believe you are genuinly invested all i can hear is you moaning about others, Well just perhaps when you posted at first it was disruptive, so to give people a chance disprove that if you want to.

I am looking forward to this period, tremendous potential and many good posters to guide us what is a tricky share We only need to understand it not be an oncologist. Take care.

Try reading my posts dear xxxxx

No Knowlesi, as ever you have twisted my words. My question was clearly how from being a lifestyle company in late 2019 do you become succesful in 2021??????????????????????????????????

As for your question about the buyer, if you can"t tell that (I can), then DYOR. Goodnight.

https://www.lse.co.uk/rns/SCLP/scancell-hlds-technology-acquired-from-university-of-nottingham-lbe9e38v11qcrzq.html

That RNS was dated 18th April 2018, just under 17 months ago. I wonder what else they have for us?? I know some people were cooncerned about how much time Lindy is away from Scancell for her duties there, I am sure with recent employees numbering 23 now and Samantha Pastons role, concerns have been diminished somewhat, but great to see such a deal come our way, of mutual benefit to both, part of that RNS.............................

Scancell will be responsible for the management, prosecution and maintenance of any patent applications assigned from the University of Nottingham to Scancell, as well as for the filing of new patent applications for the Assigned Antibodies. Under the terms of the agreement, the University of Nottingham is eligible to receive royalties on future licence revenue or net sales arising from the Assigned Antibodies.



Dr Cliff Holloway, CEO of Scancell, commented: "Prof. Durrant and the team at NUTAC have developed a versatile method to generate high-affinity monoclonal antibodies against cancer cell glycans that, when coupled to a novel method of activating the immune system, have potential as a new class of cancer immunotherapy. We believe this platform complements our existing ImmunoBody® and Moditope® platforms, significantly broadening the strength and potential of Scancell's immunotherapy pipeline."



Dr Susan Huxtable, Director of Technology Transfer for the University of Nottingham, commented: "We have great confidence in Scancell's ability to further develop University intellectual property. The mutually-beneficial relationship between Scancell and the University is an excellent example of University technology transfer in action."

Good to see the University putting their trust in ""a lifestyle company"", lol.

Really pleased with that RNS this morning, notably being non exclusive and that air of secretness for once I like. Again Vulpes would have known about that, I wonder what else they know and I get that feeling another RNS before the AGM will soon be with us. Given the resources we have had and limitations we have had in raising funds by virtue of the Market Cap afforded to us my trust and respect for the company have only been re-inforced, and really hope for those who have had theirs tested the same applies.

Think we can build on this news now, the SCIB1 trial and all we get to learn from the AGM. Whilst I understand peoples frustration I have sent my best wishes to the BOD, do they really deserve some of the stick they have got from this BB?? I think had we have broken 10p some would feel very differently, it is frustrating, but as is often the case with a buyer and a seller and lack of PI activity the SP slips. Certainly looks better today 7.50/8.30 and I believe more to come tomorrow.

Night guys

Dragon, couldn"t agree more. What is more as I have said repeatedly, it is not just the incredible advances in the Industry the past few years that we have had to contend with during clinical development, but as Ray points out even additions like Amplivant takes so much time, but we are not just achieving that, we are forging any number of advances into not just this our third platform, but in all areas surrounding our Science, autoimmune diseases and all.

Much like I recal 6/7 years ago when there were many posts attributed to so many diseases we justmight be able to treat in the future, and that reminds me of what might have progressed between us and the Karolinska Institute. Sure we haven"t heard anywhere near the last of that, and Lindys awards in Sweden suggest that might just be the case too.